Skip to main content
Fig. 3 | Renal Replacement Therapy

Fig. 3

From: Peritonitis in peritoneal dialysis patients in Japan: a 2013 retrospective questionnaire survey of Japanese Society for Peritoneal Dialysis member institutions

Fig. 3

Antibiotic therapy: administration methods and durations. a First empiric antibiotic (540 cases). b Second empiric antibiotic (406 cases). c Third antibiotic, targeted for known susceptibility (278 cases). d Fourth antibiotic, targeted for known susceptibility (79 cases). In total, 406 cases (75.2 %) were treated with combined empiric therapy; 278 cases were switched to targeted antibiotics after empiric antibiotic administration. Intraperitoneal administration: 277 (51.4 %) for first antibiotic and 236 (59.4 %) for second antibiotic. Total administration periods were 16.5 ± 9.3 days. CEZ cefazolin, CAZ ceftazidime, VCM vancomycin, CTM cefotiam, CMZ cefmetazole, TOB tobramycin, AMK amikacin, MEMP meropenem, LVFX levofloxacin, CCL cefaclor, RFP rifampicin, IP intraperitoneal cavity administration, IV intravenous administration

Back to article page